NOS2 and myeloid sarcoma: iNOS is present in actively demyelinating lesions, and the level of stable reaction products of nitric oxide, i.e., NO metabolites (NOx = nitrite + nitrate), are significantly higher in the plasma or serum of patients with MS [23,24].